Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 25
10/24/2016 1:50:15 PM
10/24/2016 1:49:48 PM
10/24/2016 1:49:21 PM
10/24/2016 1:48:58 PM
10/24/2016 12:32:28 PM
10/24/2016 12:31:44 PM
10/24/2016 12:31:11 PM
10/24/2016 11:47:15 AM
10/24/2016 11:46:09 AM
10/24/2016 11:45:21 AM
10/21/2016 2:28:20 PM
10/21/2016 2:03:45 PM
10/21/2016 2:03:22 PM
10/21/2016 2:02:39 PM
10/21/2016 2:02:10 PM
10/21/2016 1:01:13 PM
10/21/2016 1:00:21 PM
10/21/2016 12:59:44 PM
10/21/2016 12:13:01 PM
10/21/2016 12:11:45 PM
10/21/2016 12:11:11 PM
10/20/2016 2:24:55 PM
10/20/2016 2:23:49 PM
10/20/2016 2:18:31 PM
10/20/2016 2:17:50 PM
10/20/2016 2:16:58 PM
10/20/2016 2:15:53 PM
10/20/2016 2:15:04 PM
10/20/2016 2:14:28 PM
10/20/2016 2:13:06 PM
10/20/2016 1:27:39 PM
10/20/2016 1:26:49 PM
10/20/2016 1:26:18 PM
10/20/2016 12:23:41 PM
10/20/2016 12:22:48 PM
10/20/2016 12:21:53 PM
10/20/2016 11:43:44 AM
10/20/2016 11:42:38 AM
10/20/2016 11:41:46 AM
10/19/2016 12:29:48 PM
10/19/2016 11:24:30 AM
10/19/2016 11:23:12 AM
10/19/2016 11:22:16 AM
10/19/2016 9:53:19 AM
10/19/2016 9:51:33 AM
10/18/2016 1:58:29 PM
10/18/2016 12:34:47 PM
10/18/2016 12:32:02 PM
10/18/2016 11:20:24 AM
10/18/2016 11:19:00 AM
Recent Articles
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
- Investigation of MoonLake Immunotherapeutics Raises Concerns
- Leadership Changes at Silver Mountain Resources: What to Expect
- Canton Fair Launches Enhanced Services to Boost Global Trade
